Navigation Links
FCC Approval of Finite Element Method for Biomedical Transmitters Puts ANSYS Software in the Spotlight

PITTSBURGH, March 3, 2011 /PRNewswire/ -- For specific electromagnetic applications in the healthcare industry, HFSS™ software from ANSYS (Nasdaq: ANSS) can now provide proof that a biomedical device transmitter design meets Federal Communications Commission (FCC) standards -- a ruling that will enable medical device developers to cut development time and costs while meeting safety standards.


The FCC ruled in February that the finite element method (FEM) is a valid technique to simulate a medical device that must communicate with other similar devices. As a result, organizations in the medical equipment sector can use HFSS -- industry-leading FEM electromagnetic field simulation -- to validate their transmitter designs.

Today’s sophisticated medical implants and other equipment often contain transmitters that communicate with other devices -- transferring physiological data to a doctor via wireless communication, for example, which can be used to monitor, diagnose or treat a patient’s condition. The new FCC ruling applies to transmitters that are placed inside, on, or in close proximity to the human body. Developers of such medical devices must ensure that their equipment meets radio frequency (RF) emission safety standards. Additionally, manufacturers must comply with specific absorption rate (SAR) regulations, a measure of how the body absorbs energy when exposed to an RF electromagnetic field. HFSS software -- which employs FEM simulation to verify both SAR and RF emissions -- can also reduce development time and costs while increasing reliability and design optimization.

“The HFSS finite element solution is extremely valuable for designing antenna systems for implantable devices,” said Mark Lanciault, principal electrical engineer, Cambridge Consultants, Inc. “Its use of an unstructured mesh is particularly well suited for modeling the complex curved surfaces within the human body, as seen in organs, tissues, and bones. Using HFSS allows us to optimize and verify performance of our implanted antenna designs in a representative environment. We will now be able to provide our customers accurate solutions specific to their device's location in the body.”

“The medical device market is rapidly innovating to meet consumer demands and satisfy regulatory safety requirements,” said Markus Kopp, product manager for electronics at ANSYS. “This FCC ruling allows researchers to innovate with HFSS, developing new approaches that they can get to market faster -- yet also maintain the FCC’s high standards of technical compliance. Beyond that, the ultimate beneficiary is the public, who will have quicker access to life-enhancing medical devices.”

ANSYS requested that the FCC grant a waiver to the Medical Device Radiocommunication Service rules to permit FEM environmental evaluation of medical implant or body-worn equipment. The ruling granting the waiver cited scientific literature stating that FEM is a sound engineering technique.

HFSS software, which incorporates industry-leading technology for 3-D full-wave electromagnetic field simulation, enables engineers to design, simulate and validate the behavior of complex high-performance RF, microwave and millimeter-wave devices in next-generation wireless devices, defense communication systems, biomedical devices, and consumer electronics.

About Cambridge Consultants, Inc. For over 50 years, Cambridge Consultants has led the way in innovative product development. We are the development partner of choice to many of the world’s leading blue chips as well as the virtual development team for ambitious start-up companies. We develop breakthrough products, create and license intellectual property, and provide business consultancy in technology-critical issues for clients worldwide, whether they are launching first-to-market products, entering new markets or expanding existing markets.

With a team of over 300 engineers, designers, scientists and consultants, in offices in Cambridge (UK) and Boston (USA), Cambridge Consultants offers solutions across a diverse range of industries including defence, medical technology, industrial and consumer products, transport, energy, cleantech and wireless communications.  

Cambridge Consultants is part of the Altran Group, the European leader in Innovation Consulting.

About ANSYS, Inc.ANSYS, Inc., founded in 1970, develops and globally markets engineering simulation software and technologies widely used by engineers, designers, researchers and students across a broad spectrum of industries and academia. The company focuses on the development of open and flexible solutions that enable users to analyze designs directly on the desktop, providing a common platform for fast, efficient and cost-conscious product development, from design concept to final-stage testing and validation. The company and its global network of channel partners provide sales, support and training for customers. Headquartered in Canonsburg, Pa., U.S.A., with more than 60 strategic sales locations throughout the world, ANSYS, Inc. and its subsidiaries employ more than 1,600 people and distribute ANSYS products through a network of channel partners in 40+ countries. Visit for more information.

ANSYS, ANSYS Workbench, Ansoft, AUTODYN, CFX, FLUENT, and any and all ANSYS, Inc. brand, product, service and feature names, logos and slogans are registered trademarks or trademarks of ANSYS, Inc. or its subsidiaries in the United States or other countries. All other brand, product, service and feature names or trademarks are the property of their respective owners.

Technology: ANSS-TContactMedia

Fran Investors



Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
3. CryoCor Receives FDA Approval for Right Atrial Flutter
4. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
7. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
8. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
9. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
10. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
11. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  DILON Diagnostics and ... signed an agreement for DILON to distribute GE,s Discovery ... the globe. The signing of this distribution agreement will provide ... Molecular Breast Imaging system and is considered an initial ... better healthcare solutions for clinicians and their patients. ...
(Date:11/24/2015)... 24, 2015 . ... adds Latest Guidebook for Chinese Medical Device ... published in November 2015 to the medical devices ... library at . ... growing global economies with a fifth population in ...
(Date:11/24/2015)... -- Figure 1, a free mobile-first network that enables healthcare ... a new completely redesigned web version that includes uploading. ... work primarily on a desktop, to upload images directly ... user base, Figure 1 is hosting an event during ... (RSNA) Annual Meeting. Joshua Landy ...
Breaking Medicine Technology:
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software helps practice ... an agreement between the practice owner and the patient that automatically manages all ... projections. Click here to learn more. , According to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... New patients who ... a referral for dental implants at her Mississauga, ON practice. Dr. Williams ... in the placement of dental implants. , Missing teeth can lead to a ...
Breaking Medicine News(10 mins):